Operating in a simulated mid-infrared spectral region, the sensor detects subtle changes in the refractive index of oral tissues to distinguish healthy tissue from malignant lesions. The model achieved a high refractive-index sensitivity with near-perfect linearity (R2 = 0.9997), showcasing its potential as a label-free diagnostic tool.
This work is theoretical: the author modeled the sensor’s optical response to assigned refractive-index values representing healthy and cancerous oral tissue, with no devices, biological samples, or patients tested.
Download a free PDF here!
Limitations of Conventional Diagnostic Methods
Traditional diagnostic methods for oral and head-and-neck cancers rely heavily on visual examinations, medical imaging, and tissue biopsies. While these techniques are clinical standards, they can be invasive and may miss subtle biochemical changes during early cancer stages. This has driven the development of rapid, label-free optical biosensors that detect disease by measuring changes in the refractive index of biological tissues.
Among the most promising platforms are photonic crystals, which control light movement through alternating layers of materials with different refractive indices. This structure creates a photonic band gap that blocks specific wavelengths of light.
Introducing a defect layer creates a narrow optical resonance that confines light, making the sensor sensitive to small changes in the surrounding tissue. The mid-infrared region improves detection because it matches the characteristic molecular vibrations of many biological molecules.
Structural Design of the Multilayer Biosensor
The proposed biosensor employs a straightforward 1D multilayer structure that is easier to fabricate than complex two-dimensional designs. It begins with a graphene layer that enhances light confinement, followed by alternating high- and low-refractive-index dielectric layers that act as Bragg mirrors, surrounding a central defect cavity filled with oral tissue or fluid.
Researchers analyzed the sensor's optical response using the transfer matrix method (TMM), which calculates light propagation through the layered structure.
The model focuses on transverse electric (TE) polarization and compares the refractive indices of healthy and cancerous oral tissues. Additionally, changes in tissue composition alter the refractive index, thereby shifting the resonant wavelength of the defect mode. Furthermore, the study optimized the cavity thickness and the number of dielectric layers to strengthen light-matter interaction while maintaining a design suitable for thin-film fabrication.
Performance Evaluation and Spectral Characteristics
The numerical simulations showed that the proposed sensor consistently responds to changes in the refractive index of oral tissue. As the tissue transitions from a healthy to cancerous state, the higher refractive index increases the optical path length inside the defect cavity. This produces a clear redshift in the resonant wavelength.
The sensor achieved refractive-index sensitivity of about 1629.82 nm/RIU and demonstrated an almost perfectly linear response across the simulated tissue range. The resonance peak remained sharp, with an average full width at half maximum (FWHM) of 17.01 nm, leading to a quality factor of 470.25 and a figure of merit of 95.81 RIU-1.
The model also achieved a detection accuracy of 0.0588 nm-1 and a low limit of detection of 0.0104 RIU, indicating its capability to detect very small changes in tissue properties.
Electric-field simulations confirmed strong confinement of the optical field within the analyte-filled defect cavity, with rapid decay inside the surrounding Bragg mirrors. Additionally, the fabrication-tolerance analysis indicated that small variations in layer thickness had little effect on the sensor's performance, showing stable operation under realistic conditions.
Potential Clinical Implications
The high sensitivity and strong linear response of this mid-infrared sensor suggest it could have potential as a compact diagnostic sensing system. In the future, clinicians could integrate the compact chip into portable devices, enabling analysis of a small oral fluid sample or tissue smear for rapid, label-free results that distinguish healthy tissue from early-stage oral cancer. Such a system could support faster clinical decision-making and improve early disease detection.
The sensor design can also be adapted for other applications. By adjusting the cavity dimensions, operating wavelength, or dielectric materials, the device’s underlying architecture could be used to detect biomarkers such as glucose, creatinine, viral particles, and other disease-related molecules. This makes it a promising platform for various biomedical diagnostic applications.
Next Steps in Photonic Diagnostic Research
This study presents a theoretical design for a graphene-assisted photonic crystal biosensor for non-invasive oral cancer detection. The simulations demonstrate that combining high wavelength sensitivity with a sharp resonance response improves the detection of changes in tissue properties while maintaining a simple 1D design.
The next step is to validate the sensor experimentally by fabricating the device and conducting clinical tests. Future work could also integrate the sensor with microfluidic sample delivery systems and evaluate its performance under real-world conditions. Overall, this technology could support fast, label-free optical diagnostics for oral cancer and beyond.
Journal Reference
Aly, A.H. (2026). One-dimensional mid-IR defect-mode photonic crystal biosensor for oral cancer detection. Scientific Reports. 16. https://www.nature.com/articles/s41598-026-59748-5.
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.